Improving both the efficiency and long‐term stability of perovskite solar cells (PSCs) is critical for their commercial deployment. Despite the widespread use of spiro‐OMeTAD as a hole‐transporting material (HTM), its inhomogeneous doping behavior and susceptibility to moisture and heat have hindered its large‐scale industrial implementation. Here, a family of spiro‐phenothiazine‐based HTMs (PTZ) is reported to address these drawbacks. Among them, the fluorene derivative (PTZ‐Fl) shows a larger Li + affinity and forms a compact interphase by intercalation in the perovskite passivating layer that prevents Li + migration. PSCs incorporating PTZ‐Fl exhibit power conversion efficiencies (PCEs) up to 25.8% (certified 25.2% under reverse scan), retaining 80% of their initial performance after 1000 h under ISOS‐L‐3 protocol. Furthermore, a 5 × 5 cm mini‐module reaches a PCE of 22.1%, surpassing spiro‐OMeTAD‐based PSCs and retaining over 85% of its efficiency after 1100 h under ISOS‐D‐1 protocol. These results demonstrate that PTZ‐Fl not only enables high PCEs but also substantially improves operational stability, offering a promising pathway toward the large‐scale deployment of next‐generation PSCs.
No takes yet. Share an insight, caveat, or question.
Urieta‐Mora et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: